# Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

> **NCT05036252** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 23 (actual)

## Conditions studied

- Breast Cancer
- HER2-positive Breast Cancer
- HER2-positive Metastatic Breast Cancer
- Breast Cancer Stage I
- Breast Cancer Stage II
- Breast Cancer Stage III
- Breast Cancer Stage IV
- Cardiotoxicity

## Interventions

- **DIAGNOSTIC_TEST:** Cardiopulmonary Exercise Test
- **DIAGNOSTIC_TEST:** Echocardiogram
- **DIAGNOSTIC_TEST:** Echocardiography

## Key facts

- **NCT ID:** NCT05036252
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-27
- **Primary completion:** 2026-08-27
- **Final completion:** 2026-08-27
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036252, "Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05036252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*